Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with 11,916 designated donors.

R R Cordell, V A Yalon, C Cigahn-Haskell

    Transfusion
    |September 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Acute anemic events in sickle cell disease.

    Transfusion·2000
    Same author

    Kansas court denies employment discrimination claims under ADA, FMLA, and PDA.

    The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·1996
    Same author

    Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners.

    Journal of acquired immune deficiency syndromes·1994
    Same author

    Declining efficacy of AIDS case list cross-referencing in human immunodeficiency virus look-back: 1981 through 1992.

    Transfusion·1994
    Same author

    The U.S. National Marrow Donor Program.

    The American journal of pediatric hematology/oncology·1994
    Same author

    Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.

    Clinical transplants·1994

    Designated donor programs simplify participation by removing barriers. This study found designated donations are as safe as standard blood donations, ensuring patient safety without compromising blood supply integrity.

    Area of Science:

    • Transfusion Medicine
    • Blood Banking
    • Public Health

    Background:

    • Designated donor programs allow specific patients to select their blood donors.
    • Initial protocols for designated donations were complex, potentially hindering participation.
    • Patient and donor convenience are crucial for successful blood donation programs.

    Purpose of the Study:

    • To evaluate the safety and characteristics of blood donations made through a designated donor program.
    • To compare designated donations with homologous and first-time non-designated donations.
    • To assess the impact of protocol simplification on donor participation and blood safety.

    Main Methods:

    • A retrospective analysis of 11,916 designated donors from June 1984 to December 1985.

    Related Experiment Videos

  • Comparison of designated donors (n=3063) with homologous (n=3201) and first-time non-designated donors (n=3439).
  • Evaluation of deferral rates, age, sex, race, blood type, and laboratory test results across groups.

    • Main Results:

    • Simplifying the protocol increased ease of participation for donors, patients, and staff.
    • No significant differences were observed between designated, homologous, and first-time non-designated donors in key demographic and laboratory parameters.
    • Deferral rates, age, sex, race, blood type, and test results were comparable across all donor groups.

    Conclusions:

    • Simplified designated donor programs are feasible and do not compromise blood safety.
    • Designated donations are equivalent in safety to non-designated and homologous blood donations.
    • The study supports the continued use and potential expansion of accessible designated donor programs.